Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Moodys
Covington
Fish and Richardson
Argus Health
Novartis
Julphar
Johnson and Johnson
Chinese Patent Office
Cipla

Generated: October 21, 2017

DrugPatentWatch Database Preview

Blue Earth Company Profile

« Back to Dashboard

What is the competitive landscape for BLUE EARTH, and what generic alternatives to BLUE EARTH drugs are available?

BLUE EARTH has one approved drug.

There are two US patents protecting BLUE EARTH drugs.

There are thirty-three patent family members on BLUE EARTH drugs in thirteen countries.

Summary for Applicant: Blue Earth

International Patents:33
US Patents:2
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Blue Earth
AXUMIN
fluciclovine f-18
SOLUTION;INTRAVENOUS208054-001May 27, 2016RXYesYes► Subscribe► Subscribe► Subscribe
Blue Earth
AXUMIN
fluciclovine f-18
SOLUTION;INTRAVENOUS208054-001May 27, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Blue Earth
AXUMIN
fluciclovine f-18
SOLUTION;INTRAVENOUS208054-001May 27, 2016RXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Blue Earth

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,817,776 Amino acid analogs for tumor imaging► Subscribe
9,381,259Precursor compound of radioactive halogen-labeled organic compound► Subscribe
8,758,724Unnatural amino acid radiolabeling precursor► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Blue Earth Drugs

Country Document Number Estimated Expiration
Canada2237218► Subscribe
Australia720738► Subscribe
Japan5635225► Subscribe
Canada2629227► Subscribe
World Intellectual Property Organization (WIPO)2007063824► Subscribe
Taiwan200800869► Subscribe
South Korea101643991► Subscribe
China101316812► Subscribe
JapanWO2007063824► Subscribe
South Korea20080071146► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Accenture
US Department of Justice
Novartis
Mallinckrodt
Deloitte
Boehringer Ingelheim
Chinese Patent Office
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot